Hannah L F Cooper1, Brooke West1, Sabriya Linton1, Josalin Hunter-Jones1, Maria Zlotorzynska1, Ron Stall1, Mary E Wolfe1, Leslie Williams1, H Irene Hall1, Charles Cleland1, Barbara Tempalski1, Samuel R Friedman1. 1. Hannah L. F. Cooper, Sabriya Linton, Josalin Hunter-Jones, Maria Zlotorzynska, and Mary E. Wolfe are with the Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA. Brooke West is with the Division of Global Public Health, University of California at San Diego, La Jolla. Leslie Williams, Barbara Tempalski, and Samuel R. Friedman are with National Development and Research Institutes Inc, New York, NY. Ron Stall is with the Department of Behavioral and Community Health Sciences and Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA. H. Irene Hall is with the HIV Incidence and Case Surveillance Branch, Centers for Disease Control and Prevention, Atlanta. Charles Cleland is at the School of Nursing, New York University, New York, NY.
Abstract
OBJECTIVES: We sought to determine whether contextual factors shape injection drug use among Black adolescents and adults. METHODS: For this longitudinal study of 95 US metropolitan statistical areas (MSAs), we drew annual MSA-specific estimates of the prevalence of injection drug use (IDU) among Black adolescents and adults in 1993 through 2007 from 3 surveillance databases. We used existing administrative data to measure MSA-level socioeconomic status; criminal justice activities; expenditures on social welfare, health, and policing; and histories of Black uprisings (1960-1969) and urban renewal funding (1949-1974). We regressed Black IDU prevalence on these predictors by using hierarchical linear models. RESULTS: Black IDU prevalence was lower in MSAs with declining Black high-school dropout rates, a history of Black uprisings, higher percentages of Black residents, and, in MSAs where 1992 White income was high, higher 1992 Black income. Incarceration rates were unrelated. CONCLUSIONS: Contextual factors shape patterns of drug use among Black individuals. Structural interventions, especially those that improve Black socioeconomic security and political strength, may help reduce IDU among Black adolescents and adults.
OBJECTIVES: We sought to determine whether contextual factors shape injection drug use among Black adolescents and adults. METHODS: For this longitudinal study of 95 US metropolitan statistical areas (MSAs), we drew annual MSA-specific estimates of the prevalence of injection drug use (IDU) among Black adolescents and adults in 1993 through 2007 from 3 surveillance databases. We used existing administrative data to measure MSA-level socioeconomic status; criminal justice activities; expenditures on social welfare, health, and policing; and histories of Black uprisings (1960-1969) and urban renewal funding (1949-1974). We regressed Black IDU prevalence on these predictors by using hierarchical linear models. RESULTS: Black IDU prevalence was lower in MSAs with declining Black high-school dropout rates, a history of Black uprisings, higher percentages of Black residents, and, in MSAs where 1992 White income was high, higher 1992 Black income. Incarceration rates were unrelated. CONCLUSIONS: Contextual factors shape patterns of drug use among Black individuals. Structural interventions, especially those that improve Black socioeconomic security and political strength, may help reduce IDU among Black adolescents and adults.
Authors: Barbara Tempalski; Peter L Flom; Samuel R Friedman; Don C Des Jarlais; Judith J Friedman; Courtney McKnight; Risa Friedman Journal: Am J Public Health Date: 2007-01-31 Impact factor: 9.308
Authors: Samuel R Friedman; Barbara Tempalski; Joanne E Brady; Judith J Friedman; Hannah L F Cooper; Peter L Flom; Moriah M McGrath; Karla Gostnell; Don C Des Jarlais Journal: Int J Drug Policy Date: 2006-12-01
Authors: Loida E Bonney; Hannah L F Cooper; Angela M Caliendo; Carlos Del Rio; Josalin Hunter-Jones; Deanne F Swan; Richard Rothenberg; Benjamin Druss Journal: Sex Transm Dis Date: 2012-02 Impact factor: 2.830
Authors: Hannah Lf Cooper; Don C Des Jarlais; Barbara Tempalski; Brian H Bossak; Zev Ross; Samuel R Friedman Journal: Health Place Date: 2011-09-28 Impact factor: 4.078
Authors: Samuel R Friedman; Brooke S West; Enrique R Pouget; H Irene Hall; Jennifer Cantrell; Barbara Tempalski; Sudip Chatterjee; Xiaohong Hu; Hannah L F Cooper; Sandro Galea; Don C Des Jarlais Journal: PLoS One Date: 2013-02-21 Impact factor: 3.240
Authors: Umedjon Ibragimov; Stephanie Beane; Adaora A Adimora; Samuel R Friedman; Leslie Williams; Barbara Tempalski; Ron Stall; Gina Wingood; H Irene Hall; Anna Satcher Johnson; Hannah L F Cooper Journal: J Urban Health Date: 2019-12 Impact factor: 3.671
Authors: Bridgette M Brawner; Barbara Guthrie; Robin Stevens; Lynne Taylor; Michael Eberhart; Jean J Schensul Journal: J Urban Health Date: 2017-10 Impact factor: 3.671
Authors: Natalie DuPre; Lyndsey Blair; Sarah Moyer; E Francis Cook; Bert Little; Jeffrey Howard Journal: Am J Public Health Date: 2020-07-16 Impact factor: 11.561
Authors: Hannah Lf Cooper; David H Cloud; Patricia R Freeman; Monica Fadanelli; Travis Green; Connor Van Meter; Stephanie Beane; Umedjon Ibragimov; April M Young Journal: Int J Drug Policy Date: 2020-03-26
Authors: Umedjon Ibragimov; Stephanie Beane; Samuel R Friedman; Barbara Tempalski; Leslie D Williams; Sarah McKetta; Adaora A Adimora; Gina M Wingood; Ron D Stall; H Irene Hall; Anna Satcher Johnson; Hannah L F Cooper Journal: Ann Epidemiol Date: 2020-10-14 Impact factor: 3.797
Authors: Umedjon Ibragimov; Stephanie Beane; Samuel R Friedman; Kelli Komro; Adaora A Adimora; Jessie K Edwards; Leslie D Williams; Barbara Tempalski; Melvin D Livingston; Ronald D Stall; Gina M Wingood; Hannah L F Cooper Journal: PLoS One Date: 2019-10-09 Impact factor: 3.240
Authors: Kristina T Phillips; Catherine Stewart; Bradley J Anderson; Jane M Liebschutz; Debra S Herman; Michael D Stein Journal: Drug Alcohol Depend Date: 2021-02-27 Impact factor: 4.492